Header

UZH-Logo

Maintenance Infos

Position statement on the use of biosimilars in inflammatory bowel disease


Burri, Emanuel; Juillerat, Pascal; Maillard, Michel H; Manz, Michael; Michetti, Pierre; Mottet, Christian; Rogler, Gerhard; Zahnd, Nadine; Vavricka, Stephan (2019). Position statement on the use of biosimilars in inflammatory bowel disease. Swiss Medical Weekly, 149:w20148.

Abstract

Biologics are effective and have a good safety profile in the treatment of inflammatory bowel disease. Biosimilars have recently become available as treatment option. They are biological agents that are highly similar to the original biologic compound in their structure, biological activity, efficacy and safety. This position paper summarises current knowledge on biosimilars and presents its statements on regulatory issues and clinical situation in order to provide clinicians adequate information for them to reach informed and appropriate shared decision-making with their patients.

Abstract

Biologics are effective and have a good safety profile in the treatment of inflammatory bowel disease. Biosimilars have recently become available as treatment option. They are biological agents that are highly similar to the original biologic compound in their structure, biological activity, efficacy and safety. This position paper summarises current knowledge on biosimilars and presents its statements on regulatory issues and clinical situation in order to provide clinicians adequate information for them to reach informed and appropriate shared decision-making with their patients.

Statistics

Citations

Dimensions.ai Metrics

Altmetrics

Downloads

90 downloads since deposited on 10 Jan 2020
67 downloads since 12 months
Detailed statistics

Additional indexing

Item Type:Journal Article, refereed, original work
Communities & Collections:04 Faculty of Medicine > University Hospital Zurich > Clinic for Gastroenterology and Hepatology
Dewey Decimal Classification:610 Medicine & health
Scopus Subject Areas:Health Sciences > General Medicine
Uncontrolled Keywords:General Medicine
Language:English
Date:2 December 2019
Deposited On:10 Jan 2020 14:07
Last Modified:22 Apr 2020 21:44
Publisher:EMH Swiss Medical Publishers
ISSN:0036-7672
OA Status:Gold
Free access at:Publisher DOI. An embargo period may apply.
Publisher DOI:https://doi.org/10.4414/smw.2019.20148
PubMed ID:31800086

Download

Gold Open Access

Download PDF  'Position statement on the use of biosimilars in inflammatory bowel disease'.
Preview
Content: Published Version
Filetype: PDF
Size: 602kB
View at publisher
Licence: Creative Commons: Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)